StockNYSE · US · USDHealthcare · Diagnostics & Research
$MTD
METTLER TOLEDO INTERNATIONAL INC/
Mettler-Toledo supplies precision instruments and related services to customers in industries including life sciences, food, chemicals, manufacturing, transportation and logistics, and food retail. Its five reportable segments are U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other Operations. Its products include laboratory balances, pipettes, analytical and process measurement instruments, industrial weighing equipment, product inspection systems, and retail weighing solutions. It also offers software platforms, including LabX, and services such as calibration, maintenance, regulatory compliance support, and replacement parts. Mettler-Toledo sells through direct and indirect channels, with sales through direct channels exceeding those through indirect channels. It makes money from instrument and software sales and from services, including service contracts, on-demand work, and replacement parts. Its products are sold in more than 140 countries, and it has a direct presence in approximately 40 countries. Mettler-Toledo is headquartered in Columbus, Ohio.
Mettler-Toledo International (MTD) has risen 25.2% in two months, defying a biotech funding slowdown. The company, a key supplier of precision lab instruments, benefits from regulatory requirements in commercial drug production. Q3 results showed $1.09B revenue, $12.57 adjusted EPS, and strong margins. Management's 2026-2027 EPS guidance exceeds Wall Street estimates, with free cash flow supporting share buybacks.
Mettler Toledo London employees ratified a 3-year agreement with wage hikes (5%, 3%, 3%) and improved benefits. The deal includes better safety allowances, insurance, and pension plans. The company is a global supplier of precision instruments.
Mettler Toledo's Head of Process Analytics, Keller Gerry, sold 435 shares at $1,734.05 each, totaling $754,313. Gerry now directly owns 259 shares, according to an SEC filing.
via TradingView
MTD sentiment & insider activity
Recent MTD coverage spans financial news, earnings and insider activity.
In the last 30 days, MTD insiders filed 2 SEC Form 4 transactions — no purchases and 2 sales ($754K). The most active reporter was Keller Gerry, Head of Process Analytics, with 2 filings.
AlphAI scores every news story that mentions MTD with an AI model for sentiment and relevance, and aggregates insider trades from METTLER TOLEDO INTERNATIONAL INC/'s SEC EDGAR Form 4 filings. Figures refresh continuously.
Mettler-Toledo International (MTD) has risen 25.2% in two months, defying a biotech funding slowdown. The company, a key supplier of precision lab instruments, benefits from regulatory requirements in commercial drug production. Q3 results showed $1.09B revenue, $12.57 adjusted EPS, and strong margins. Management's 2026-2027 EPS guidance exceeds Wall Street estimates, with free cash flow supporting share buybacks.
Mettler Toledo London employees ratified a 3-year agreement with wage hikes (5%, 3%, 3%) and improved benefits. The deal includes better safety allowances, insurance, and pension plans. The company is a global supplier of precision instruments.
Mettler Toledo's Head of Process Analytics, Keller Gerry, sold 435 shares at $1,734.05 each, totaling $754,313. Gerry now directly owns 259 shares, according to an SEC filing.
Keller Gerry (Head of Process Analytics) sold 435 shares of METTLER TOLEDO INTERNATIONAL INC/ (MTD) at an average of $1734.05 ($1733.76–$1738.88, $0.75M total) across 2 trades on 2026-11-09.
JP Morgan kept Mettler-Toledo Intl at Neutral but raised its price target to $1725 from $1550, an 11.3% increase. The new target aligns with the stock's recent close of $1722.15. Other recent analyst targets range from $1575 to $1900.
Stifel kept its Buy rating for Mettler-Toledo Intl and increased its price target to $1900 from $1600, suggesting a 10.3% upside from the Nov 6 close of $1722.15. The new target represents an 18.8% increase.
Mettler-Toledo International Inc. projects 2027 adjusted EPS of $52.50 to $53.50, with 5% local-currency sales growth. China sales rose 13% in Q3, with mid-teens growth expected in Q4. The company cites risks from European economic conditions, inflation, and tariffs.
Mettler-Toledo (MTD) reported Q3 gross margin expansion to 59.8% and adjusted operating profit growth of 8%. The company raised its 2026 sales growth forecast to 5% and issued 2027 guidance, expecting 5% sales growth and adjusted EPS of $52.50-$53.50. Management highlighted opportunities in automation, digitalization, and U.S. onshoring, with potential upside from AI-driven instrument upgrades.
Mettler-Toledo (MTD) reported Q3 2026 sales of $1.094B, up 6% YoY, and adjusted EPS of $12.57, up 13% YoY. The company raised its full-year adjusted EPS guidance to $47.70–$47.90 from $47.15–$47.50 and forecasted 2027 adjusted EPS of $52.50–$53.50.
JPMorgan raised its price target for Mettler-Toledo International to $1,550 from $1,400. The stock is currently trading at $1,598.03. Morgan Stanley also increased its target to $1,575 from $1,450.